MBCT
Mindfulness-Based Cognitive Therapy for Depression Relapse
Evidence grade varies by use. See the breakdown on the entry. Read how the Atlas grades evidence.
MBCT is one of the few grade 5 entries in the library, and the grade is specific to one use: preventing relapse in people with recurrent major depression. Multiple meta-analyses show it reduces relapse risk, with the largest benefit in those with three or more prior episodes, and individual-patient-data analyses find it comparable to maintenance antidepressants for that group. The UK NICE guidelines recommend it. For acute depression as a standalone treatment, the evidence is weaker.
Reference only. Not medical advice.
| Treatment | Grade | Notes |
|---|---|---|
| Relapse prevention, recurrent depression (3+ episodes) | 5 of 5 | Meta-analyses; NICE-recommended; comparable to maintenance medication. |
| Acute major depression (standalone) | 2 of 5 | Not its validated use; weaker evidence. |
| Anxiety and general wellbeing | 3 of 5 | Reasonable but less specific than its relapse indication. |
What can go wrong
Generally safe. As with any intensive meditation, a minority of people, especially those with active trauma or severe current depression, can find sustained inward attention distressing, so it is delivered as a relapse-prevention program for people not in acute crisis. It complements rather than replaces treatment for an active depressive episode.
This is something to take to a clinician. The Atlas can tell you what is known about mbct in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
MBCT is among the strongest evidence entries in the entire library, and the lineage behind it matters as much as the data. Its mindfulness core is Buddhist Vipassana, documented in the Pali Canon and democratized by the twentieth-century Burmese revival before Segal, Williams, and Teasdale fused it with cognitive therapy in the late 1990s. The result is a manualized eight-week course with a precise, well-supported use: preventing relapse in people with recurrent major depression. Multiple meta-analyses and the UK NICE guidelines back it, and for people with three or more prior episodes it performs comparably to staying on antidepressants. We grade that relapse-prevention use at grade 5 and are careful to note that acute-depression treatment, a different question, has weaker support.
One of the strongest evidence entries in the library: a structured eight-week program that prevents depression relapse about as well as staying on antidepressants in people with recurrent episodes.
How it works
Established and proposed: MBCT is thought to work by changing the relationship to depressive thoughts rather than their content, interrupting the automatic ruminative loops that drive relapse. Mindfulness training appears to reduce reactivity to sad mood and to weaken the cognitive patterns (overgeneral memory, rumination) that reactivate depression. These are reasonably well-characterized cognitive mechanisms, though the precise neural pathways remain an active research area.
What people get wrong
Often saidMBCT is just relaxation or generic meditation.
ActuallyIt is a specific, manualized program combining mindfulness with cognitive therapy, validated for a specific outcome: preventing depressive relapse.
Often saidIt treats active depression as well as it prevents relapse.
ActuallyIts strongest evidence is for relapse prevention in recurrent depression. For an acute episode the evidence is weaker and it is not first-line.
Who profits, and who pushes back
Segal, Williams, and Teasdale
Designed MBCT specifically to interrupt the ruminative patterns that drive depressive relapse.
NICE (UK)
Recommends MBCT for people with recurrent depression to prevent relapse.
Meta-analysts
Find the largest relapse-prevention benefit in those with three or more prior episodes.
Contemplative-lineage teachers
Note that the clinical program draws on a 2,500-year Buddhist practice whose teachers are rarely credited.
Where the research comes from
Most of the published research on this comes from one place. 90% of it is from United Kingdom (NICE-recommended). Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| United Kingdom (NICE-recommended) | 90% |
| North America | 84% |
| Europe | 80% |
| Asia (source lineage) | 70% |
How we got here
MBCT's attentional core is not a Western invention; it is Buddhist. The mindfulness it teaches descends from Vipassana practice documented in the Pali Canon around the first century BCE, rooted in the Buddha's teaching in India around 500 BCE and in pre-Buddhist Indian contemplative traditions older still. The Burmese revival of the nineteenth and twentieth centuries, through teachers such as Ledi Sayadaw and Mahasi Sayadaw, democratized the practice for lay people, and it was that accessible form that reached the West. Zindel Segal, Mark Williams, and John Teasdale assembled MBCT in the late 1990s by joining this contemplative core to cognitive therapy, specifically to prevent depressive relapse.
Building on Kabat-Zinn's MBSR, the three developers created MBCT in the late 1990s to target depressive relapse, publishing the foundational manual in 2002. Meta-analyses through the 2000s and 2010s established its relapse-prevention effect, and NICE incorporated it into UK depression guidance. The same period saw growing acknowledgment that the practice rests on a long Buddhist lineage that secular clinical framing had largely erased.
- c. 500 BCEBuddhist contemplative roots in India
- 1st c. BCEVipassana documented in the Pali Canon
- 19th-20th c.Burmese revival democratizes lay practice
- Late 1990sSegal, Williams, Teasdale develop MBCT
- 2002Foundational manual published
- 2000s-2010sMeta-analyses and NICE recommendation establish relapse-prevention role
How it is understood
MBCT is delivered as a manualized eight-week group course of weekly sessions plus home practice, combining mindfulness meditation (breath, body scan, and awareness of thoughts) with cognitive-therapy elements that help people relate differently to depressive thinking. It is offered in health systems as a relapse-prevention program rather than an acute-depression treatment.
At a glance
- Developers
- Segal, Williams, Teasdale, late 1990s
- Format
- Eight-week group course
- Best evidence
- Recurrent-depression relapse prevention
- Guideline
- NICE-recommended (UK)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about MBCT. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.